Peter Svennilson, Director, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 583,092 shares at $11.77 ($6.8M) on 2020-03-20, disclosed to the SEC on 2020-03-23.
Open-market purchase of $6.8M NGM by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.59 | 148,464 | $1.7M | 25.3% |
| 2 | $11.59 | 148,464 | $1.7M | 25.3% |
| 3 | $11.77 | 143,082 | $1.7M | 24.7% |
| 4 | $11.77 | 143,082 | $1.7M | 24.7% |
| Total | $11.68 avg | 583,092 | $6.8M | 100% |
| Filing → |
| NGM | BUY | 2022-06-06 | $877K | — | Filing → |
| NGM | BUY | 2022-05-19 | $4.0M | — | Filing → |
| RAPT | SELL | 2021-08-24 | $5.4M | — | Filing → |